Recursion Pharma director Christopher Gibson sells $144,800 in stock

Created at 5 Jun · 21:22 UTC2 sources2 events

IN SHORT

Recursion Pharmaceuticals director Christopher Gibson sold $144,800 worth of the company's stock. This follows a recent sale by CEO Najat Khan.

Key Numbers

$144,800value of stock sold by director

Who's Involved

Christopher Gibson

Director of Recursion Pharmaceuticals

Key facts

Recursion Pharmaceuticals director Christopher Gibson sold $144,800 in stock.
The transaction involved the sale of Recursion Pharma stock.

Recursion Pharmaceuticals director Christopher Gibson has sold $144,800 worth of the company's stock. This sale follows a recent transaction by CEO Najat Khan, who sold $84,459 in stock.

↳ Why This Matters

Insider selling can sometimes signal a lack of confidence in future stock performance, potentially influencing investor sentiment.

FREQUENTLY ASKED

Christopher Gibson is a director at Recursion Pharmaceuticals.

He sold $144,800 worth of Recursion Pharmaceuticals stock.

The ticker symbol for Recursion Pharmaceuticals is RXRX.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence

CME Headlines

Key facts

Recursion Pharmaceuticals director Christopher Gibson sold $144,800 in stock.

The transaction involved the sale of Recursion Pharma stock.

Recursion Pharmaceuticals director Christopher Gibson has sold $144,800 worth of the company's stock. This sale follows a recent transaction by CEO Najat Khan, who sold $84,459 in stock.

Recursion Pharma director Christopher Gibson sells $144,800 in stock

PiQ Daily

Key facts

Get the newsletter.

Recursion Pharma director Christopher Gibson sells $144,800 in stock

PiQ Daily

Key facts

Get the newsletter.